Core Insights - Fortrea (Nasdaq: FTRE) has partnered with Veeva Systems Inc. and Advarra to enhance clinical trial solutions, aiming to streamline processes and improve efficiency in clinical research [1][2][3] Group 1: Company Overview - Fortrea is focused on providing solutions for clinical trials, specifically targeting I-IV phase trials, and aims to address the complexities involved in the clinical trial process [2] - The company has established a robust network of over 90 partners, employing approximately 19,000 professionals to support its clinical trial operations [2] Group 2: Strategic Partnerships - The collaboration with Veeva and Advarra is intended to simplify trial management and enhance the overall quality of clinical research [1] - Fortrea's partnership strategy is designed to leverage the strengths of its partners to deliver comprehensive solutions for clinical trial management [1][2] Group 3: Market Position - Fortrea is positioned to address the growing demand for efficient clinical trial solutions, which is critical given the increasing complexity of clinical research [2] - The company aims to improve patient engagement and streamline the trial process, which is essential for meeting the evolving needs of the healthcare industry [1][2]
Fortrea 與 Veeva 及 Advarra 建立行業合作夥伴關係，以精簡患者和研究機構的臨床試驗體驗